These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1100591)

  • 21. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
    Bailey RR; Peddie BA
    N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the antibacterial activity of sulphonamide-trimethoprim combinations.
    Fourie ED; van Straten AM; Maritz HC; van Rensburg AJ
    S Afr Med J; 1979 Mar; 55(14):544-7. PubMed ID: 377523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains.
    Moorhouse EC; Farrell W
    J Med Microbiol; 1973 May; 6(2):249-52. PubMed ID: 4575275
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sulfamethoxazole-trimethoprim: bacteriological experiences after 5 years of use].
    Kayser FH; Santanam P
    Schweiz Med Wochenschr; 1974 Dec; 104(52):1950-4. PubMed ID: 4215133
    [No Abstract]   [Full Text] [Related]  

  • 25. Trimethoprim resistance and single-agent use.
    Maskell R; Pead L
    Lancet; 1989 Sep; 2(8662):557-8. PubMed ID: 2570249
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 27. A reappraisal of the antibacterial action of cotrimoxazole in vitro.
    Lewis EL; Anderson JD; Lacey RW
    J Clin Pathol; 1974 Feb; 27(2):87-91. PubMed ID: 4596417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The combination sulfamethoxazole-trimethoprim in vitro].
    Linzenmeier G; Neussel H
    Zentralbl Bakteriol Orig A; 1972 Sep; 221(4):511-26. PubMed ID: 4144946
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
    Gärtner H; Dieterich F
    Arzneimittelforschung; 1973 Apr; 23(4):597-600. PubMed ID: 4197072
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sensitization test against trimethoprim-sulfamethoxazole].
    Tauchnitz C; Tattermann G
    Z Gesamte Inn Med; 1972 May; 27(9):390-5. PubMed ID: 4626641
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Co-trimoxazole resistance.
    Then R; Angehrn P
    Br Med J; 1974 Jan; 1(5897):78-9. PubMed ID: 4590994
    [No Abstract]   [Full Text] [Related]  

  • 32. Trimethoprim-sulfamethoxazole. Comparison of synergistic combinations.
    Griffith RS
    J Infect Dis; 1973 Nov; 128():Suppl:545-6. PubMed ID: 4585957
    [No Abstract]   [Full Text] [Related]  

  • 33. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.
    Amyes SG
    Antimicrob Agents Chemother; 1982 Feb; 21(2):288-93. PubMed ID: 7041815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance testing of the pathogens in urinary tract infections on agar dip-slides].
    Büsser E; Binswanger U
    Schweiz Med Wochenschr; 1973 Sep; 103(37):1294-7. PubMed ID: 4201354
    [No Abstract]   [Full Text] [Related]  

  • 36. [Problems in the testing of enterococcal resistance to trimethoprim-sulfamethoxazole].
    Tiesler E; Braun R
    Fortschr Med; 1976 Nov; 94(32):1885-9. PubMed ID: 825424
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of emergence of bacterial resistance by combination of two antibiotics: rifampicin and trimethoprim.
    Grüneberg RN; Emmerson AM
    J Antimicrob Chemother; 1980 May; 6(3):349-56. PubMed ID: 6995419
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sensitivity of enterobacteriaceae to sulfamethoxazole (SMZ), trimethoprim (TMP) and cotrimexazole (SMZ plus TMP)].
    Lynch B; Valenzuela MC; Donoso E; Cofre J; Vilches A; Aguero ME
    Rev Chil Pediatr; 1975; 46(1):17-9. PubMed ID: 1178944
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sensitivity of Klebsiella to antibiotics. Study of 50 strains from cases of "extra" and "intrahospital" septicemia].
    Trolin C; Schoutens E; Yourassowsky E
    Pathol Biol (Paris); 1973 Jun; 21(6):581-5. PubMed ID: 4581191
    [No Abstract]   [Full Text] [Related]  

  • 40. Joint trimethoprim and sulphamethoxazole resistance in bacteria infected with R factors.
    Pinney RJ; Smith JT
    J Med Microbiol; 1973 Feb; 6(1):13-9. PubMed ID: 4570475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.